2021
DOI: 10.3892/etm.2021.9633
|View full text |Cite
|
Sign up to set email alerts
|

Visual impairment in immunoglobulin G4‑related disease: A case report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 24 publications
0
2
0
Order By: Relevance
“…The ophthalmologic clinical hallmark of IgG4-related ocular disease is bilateral lacrimal gland enlargement with three features: suborbital nerve enlargement [7], exophthalmos, and compressive optic neuropathy [4]. IgG4-related optic neuropathy is commonly caused by compression of the optic nerve by enlargement of the lacrimal glands or other intraorbital tissues [4,[8][9][10][11]. Few studies have reported on optic neuropathy caused by compression of the optic chiasm by an enlarged pituitary gland, as in the present case [5,10,11].…”
Section: Discussionmentioning
confidence: 99%
“…The ophthalmologic clinical hallmark of IgG4-related ocular disease is bilateral lacrimal gland enlargement with three features: suborbital nerve enlargement [7], exophthalmos, and compressive optic neuropathy [4]. IgG4-related optic neuropathy is commonly caused by compression of the optic nerve by enlargement of the lacrimal glands or other intraorbital tissues [4,[8][9][10][11]. Few studies have reported on optic neuropathy caused by compression of the optic chiasm by an enlarged pituitary gland, as in the present case [5,10,11].…”
Section: Discussionmentioning
confidence: 99%
“…In addition to contraindications, corticosteroids are recommended as first-line drugs for relief induction in all active or untreated IgG4-RD patients. [7][8][9] Patients with IgG4-RD are prone to disease recurrence and cancer risk during maintenance treatment. The following is a summary of IgG4-RD related treatment options.…”
Section: Treatmentmentioning
confidence: 99%